Diagnosis and management of childhood obstructive sleep apnea syndrome
CL Marcus, LJ Brooks, SD Ward, KA Draper… - …, 2012 - publications.aap.org
OBJECTIVE: This technical report describes the procedures involved in developing
recommendations on the management of childhood obstructive sleep apnea syndrome (OSAS). …
recommendations on the management of childhood obstructive sleep apnea syndrome (OSAS). …
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Z Sondka, S Bamford, CG Cole, SA Ward… - Nature Reviews …, 2018 - nature.com
… S, suppresses. Cancer hallmarks image in part a adapted with permission from ref. , Cell …
for oestradiol-induced progression through the G1–S transition, and its loss results in apoptosis …
for oestradiol-induced progression through the G1–S transition, and its loss results in apoptosis …
Recommendations on the use of exercise testing in clinical practice
P Palange, SA Ward, KH Carlsen… - European …, 2007 - Eur Respiratory Soc
… often supported by measurements of variables such as arterial oxygen saturation (S p,O 2 ,
used here in preference to the more conventional abbreviation S a,O 2 , to reflect the fact that …
used here in preference to the more conventional abbreviation S a,O 2 , to reflect the fact that …
COSMIC: the catalogue of somatic mutations in cancer
…, SL Thompson, S Wang, S Ward… - Nucleic acids …, 2019 - academic.oup.com
… In parallel with COSMIC’s deep and broad variant coverage, the Cancer Gene Census (CGC)
describes a curated catalogue of genes driving every form of human cancer. Currently …
describes a curated catalogue of genes driving every form of human cancer. Currently …
Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events: deliberations of the sleep apnea …
… 25 Griffiths AMaul JWilson AStick SImproved detection of obstructive events in childhood
sleep apnoea with the use of the nasal cannula and the differentiated sum signalJ Sleep Res…
sleep apnoea with the use of the nasal cannula and the differentiated sum signalJ Sleep Res…
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
…, M Ding, S Bamford, C Cole, S Ward… - Nucleic acids …, 2015 - academic.oup.com
COSMIC, the Catalogue Of Somatic Mutations In Cancer ( http://cancer.sanger.ac.uk ) is the
world's largest and most comprehensive resource for exploring the impact of somatic …
world's largest and most comprehensive resource for exploring the impact of somatic …
COSMIC: somatic cancer genetics at high-resolution
…, N Bindal, J Tate, CG Cole, S Ward… - Nucleic acids …, 2017 - academic.oup.com
COSMIC, the Catalogue of Somatic Mutations in Cancer ( http://cancer.sanger.ac.uk ) is a
high-resolution resource for exploring targets and trends in the genetics of human cancer. …
high-resolution resource for exploring targets and trends in the genetics of human cancer. …
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
The early detection of relapse following primary surgery for non-small-cell lung cancer and
the characterization of emerging subclones, which seed metastatic sites, might offer new …
the characterization of emerging subclones, which seed metastatic sites, might offer new …
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
…, C Munro, TL Hawkins, T Sepp, JBM Ali, S Ward… - Science, 1997 - science.org
… The sequence homology of hamartin to a putative S. pombe protein suggests that it may
participate in an evolutionarily conserved pathway of eukaryotic cell growth regulation. The …
participate in an evolutionarily conserved pathway of eukaryotic cell growth regulation. The …
[HTML][HTML] Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
G Suntharalingam, MR Perry, S Ward… - … England Journal of …, 2006 - Mass Medical Soc
<p id="p001">Six healthy young male volunteers at a contract research organization were
enrolled in the first phase 1 clinical trial of TGN1412, a novel superagonist anti-CD28 …
enrolled in the first phase 1 clinical trial of TGN1412, a novel superagonist anti-CD28 …